Abstract
Background
Kallmann syndrome (KS) is defined by the association of hypogonadotropic hypogonadism and anosmia. It is characterized by a significant clinical and genetic heterogeneity; actually, it may present several non-reproductive non-olfactory anomalies, and all the ways of genetic transmission can be involved in the inheritance of the disease. Although six pathogenesis-related genes have been identified so far, KS remains sporadic in 70 % of the cases, and the genetic diagnosis is not available for all of them. The purpose of this paper is to present a further disease that can enrich the wide spectrum of KS variability, that is cerebral arachnoid cyst.
Case description
This 11-year-old boy presented with the typical characteristics of KS together with those related to a sylvian arachnoid cyst. He was admitted because of worsening headache. At the admission, the physical examination revealed eunuchoid aspect, micropenis, previous cryptorchidism, and anosmia. MRI pointed out a large, left sylvian arachnoid cyst, agenesia of the olfactory bulbs/tracts complex, and hypoplasia of the left olfactory sulcus. The child was operated on by endoscopic fenestration of the cyst, followed by transient external drainage for subdural hygroma and microscopic fenestration for recurrence of the cyst. His statural growth is normal but the sexual development still delayed in spite of hormone replacement therapy.
Conclusion
According to the present and the other four cases in the literature, arachnoid cyst should be included among the anomalies possibly accompanying KS date although this association seems to be occasional as far as embryogenesis and physiopathology are concerned.
Similar content being viewed by others
References
Maestre de San Juan A (1856) Teratología: falta total de los nervios olfatorios con anosmia en un individuo en quien existe una atrofia congénita de los testículos y miembro viril. El Siglo Med 3:218–222 [Spanish]
Kallmann F, Schoenfeld WA, Barrera SE (1944) The genetic aspects of primary eunuchoidism. Am J Ment Defic 48:203–236
Dodé C, Levilliers J, Dupont JM, De Paepe A, Le Dû N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pêcheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-Van De Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463–465
Dodé C, Hardelin JP (2009) Kallmann syndrome. Eur J Hum Genet 17:139–146
Fernandes YB, Guerra Júnior G, Lemos SH, Matias MT, Damasceno BP, Hamamoto O, Marconi Júnior A, Honorato DC, Marins JL (1995) Unusual association of Kallmann syndrome and arachnoid cyst of the middle fossa. Report of a case. Arq Neuropsiquiatr 53:662–666 [Spanish]
Scuotto A, Accardo C, Rotondo M, Profeta L, Barbato R, Napolitano L, Lalli E, Amato G, Cirillo S (2002) Unusual association of Kallmann syndrome with empty sella and arachnoid cyst. Riv Neuroradiol 15:751–755
Takahashi MP, Miyai I, Matsumura T, Nozaki S, Kang J (1997) A case of Kallmann syndrome with empty sella and arachnoid cyst. Rinsho Shinkeigaku 37:704–777 [Japanese]
Tasar M, Bozlar U, Yetiser S, Bolu E, Tasar A, Gonul E (2005) Idiopathic hypogonadotrophic hypogonadism associated with arachnoid cyst of the middle fossa and forebrain anomalies: presentation of an unusual case. J Endocrinol Invest 28:935–939
Shin SJ, Sul Y, Kim JH, Cho JH, Kim GH, Kim JH, Choi JH, Yoo HW (2015) Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience. Ann Pediatr Endocrinol Metab 20:27–33
Tickotsky N, Moskovitz M (2014) Renal agenesis in Kallmann syndrome: a network approach. Ann Hum Genet 78:424–433
Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, Raivio T (2011) Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis 6:41
Kim SH (2015) Congenital hypogonadotropic hypogonadism and Kallmann syndrome: past, present, and future. Endocrinol Metab (Seoul) 30:456–466
Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C (2015) Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 11(9):547–64
Cadman SM, Kim SH, Hu Y, González-Martínez D, Bouloux PM (2007) Molecular pathogenesis of Kallmann’s syndrome. Horm Res 67:231–242
Abreu AP, Trarbach EB, de Castro M, Frade Costa EM, Versiani B, Matias Baptista MT, Garmes HM, Mendonca BB, Latronico AC (2008) Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 93:4113–4118
Canto P, Munguía P, Söderlund D, Castro JJ, Méndez JP (2009) Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J Androl 30(1):41–45
Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-Van Der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH (2009) CHD7 mutations in patients initially diagnosed with Kallmann syndrome—the clinical overlap with CHARGE syndrome. Clin Genet 75:65–71
Hardelin JP, Julliard AK, Moniot B, Soussi-Yanicostas N, Verney C, Schwanzel-Fukuda M, Ayer-Le Lievre C, Petit C (1999) Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev Dyn 215:26–44
Sato N, Katsumata N, Kagami M, Hasegawa T, Hori N, Kawakita S, Minowada S, Shimotsuka A, Shishiba Y, Yokozawa M, Yasuda T, Nagasaki K, Hasegawa D, Hasegawa Y, Tachibana K, Naiki Y, Horikawa R, Tanaka T, Ogata T (2004) Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J Clin Endocrinol Metab 89:1079–1088
Fechner A, Fong S, Mcgovern P (2008) A review of Kallmann syndrome: genetics, pathophysiology, and clinical management. Obstet Gynecol Surv 63:189–194
Chung WC, Moyle SS, Tsai PS (2008) Fibroblast growth factor 8 signaling through Fgf receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons. Endocrinology 149:4997–5003
Matsumoto S, Yamazaki C, Masumoto KH et al (2006) Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci U S A 103:4140–4145
Ian Hutchin B, Damla Kota L, Taylor-Burd C, Ozkan Y, Cheng PJ, Gurbuz F, Tiong JD, Mengen E, Yuksel B, Kemal Topalogl A, Wra S (2016) CCDC141 mutation identified in anosmic hypogonadotropic hypogonadism (Kallmann syndrome) alters GnRH neuronal migration. Endocrinology 157:1956–1966
Cheng PK, Chanoine JP (2001) Should the definition of micropenis vary according to ethnicity? Horm Res 55:278–281
Bry-Gauillard H, Trabado S, Bouligand J, Sarfati J, Francou B, Salenave S, Chanson P, Brailly-Tabard S, Guiochon-Mantel A, Young J (2010) Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics. Ann Endocrinol 71:158–162
Sarfati J, Bouvattier C, Bry-Gauillard H, Cartes A, Bouligand J, Young J (2015) Kallmann syndrome with FGFR1 and KAL1 mutations detected during fetal life. Orphanet J Rare Dis 10:71
Kaplan JD, Bernstein JA, Kwan A, Hudgins L (2010) Clues to an early diagnosis of Kallmann syndrome. Am J Med Genet 152A:2796–2801
Pasqualini RQ, Bur G (1955) Hypoandrogenic syndrome with spermatogenesis. Fertil Steril 6:144–157
Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94:176–178
Tusset C, Trarbach EB, Silveira LF, Beneduzzi D, Montenegro L, Latronico AC (2011) Clinical and molecular aspects of congenital isolated hypogonadotropic hypogonadism. Arq Bras Endocrinol Metabol 55:501–511
Fuerxer F, Carlier R, Iffenecker C, Schaison G, Doyon D (1996) Magnetic resonance imaging of the olfactory pathways in Kallmann de Morsier syndrome. J Neuroradiol 23:223–230
Quinton R, Duke VM, de Zoysa PA, Platts AD, Valentine A, Kendall B, Pickman S, Kirk JM, Besser GM, Jacobs HS, Bouloux PM (1996) The neuroradiology of Kallmann’s syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 81:3010–3017
Manara R, Salvalaggio A, Favaro A, Palumbo V, Citton V, Elefante A, Brunetti A (2014) Brain changes in Kallmann syndrome. Am J Neuroradiol 35(9):1700–1706
Zaghouani H, Slim I, Zina NB, Mallat N, Tajouri H, Kraiem C (2013) Kallmann syndrome: MRI findings. Indian J Endocrinol Metab 17:142–145
Madan R, Sawlani V, Gupta S, Phadke RV (2004) MRI findings in Kallmann syndrome. Neurol India 52:501–503
Zhang Z, Sun X, Wang C, Wang G, Zhao B (2016) Magnetic resonance imaging findings in Kallmann syndrome: 14 cases and review of the literature. J Comput Assist Tomogr 40:39–42
Young J (2012) Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 97:707–718
Dwyer AA, Raivio T, Pitteloud N (2015) Gonadotrophin replacement for induction of fertility in hypogonadal men. Best Pract Res Clin Endocrinol Metab 29:91–103
Grumbach MM (2005) A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90:3122–3127
Castañeyra-Perdomo A, Castañeyra-Ruiz L, González-Marrero I, Castañeyra-Ruiz A, Gonzalez-Toledo JM (2014) Early treatment of Kallmann syndrome may prevent eunuchoid appearance and behavior. Med Hypotheses 82:74–76
Maione L, Cantone E, Nettore IC, Cerbone G, De Brasi D, Maione N, Young J, Di Somma C, Sinisi AA, Iengo M, Macchia PE, Pivonello R, Colao A (2016) Flavor perception test: evaluation in patients with Kallmann syndrome. Endocrine 52:236–246
Di Rocco C (1996) Arachnoid cysts. In: Youmans IR (ed) Neurological surgery. WB Saunders, Philadelphia, pp 967–994
Galassi E, Tognetti F, Gaist G, Fagioli L, Frank F, Frank G (1982) CT scan and metrizamide CT cisternography in arachnoid cysts of the middle cranial fossa: classification and pathophysiological aspects. Surg Neurol 17:363–369
Huang JH, Mei WZ, Chen Y, Chen JW (2015) Analysis on clinical characteristics of intracranial arachnoid cysts in 488 pediatric cases. Int J Clin Exp Med 8:18343–18350
Di Rocco C (2010) Sylvian fissure arachnoid cysts: we do operate on them but should it be done? Childs Nerv Syst 26:173–175
Di Rocco C, Tamburrini G, Caldarelli M, Velardi F, Santini P (2003) Prolonged ICP monitoring in Sylvian arachnoid cysts. Surg Neurol 60:211–218
Gangemi M, Seneca V, Colella G, Cioffi V, Imperato A, Maiuri F (2011) Endoscopy versus microsurgical cyst excision and shunting for treating intracranial arachnoid cysts. J Neurosurg Pediatr 8:158–164
Schulz M, Kimura T, Akiyama O, Shimoji K (2015) Endoscopic and microsurgical treatment of sylvian fissure arachnoid cysts—clinical and radiological outcome. World Neurosurg 84:327–336
Tamburrini G, Dal Fabbro M, Di Rocco C (2008) Sylvian fissure arachnoid cysts: a survey on their diagnostic workout and practical management. Childs Nerv Syst 24:593–604
Tamburrini G, Caldarelli M, Massimi L, Santini P, Di Rocco C (2003) Subdural hygroma: an unwanted result of Sylvian arachnoid cyst marsupialization. Childs Nerv Syst 19:159–165
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Massimi, L., Izzo, A., Paternoster, G. et al. Arachnoid cyst: a further anomaly associated with Kallmann syndrome?. Childs Nerv Syst 32, 1607–1614 (2016). https://doi.org/10.1007/s00381-016-3154-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-016-3154-7